Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lianhua Qingwen Granule for pediatric RSV pneumonia
ChiCTR2200057146Phase 4Not yet recruiting
- Sponsor
- Jiangsu Provincial Hospital of Traditional Chinese Medicine
- Start
- May 2022
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Lianhua Qingwen in respiratory syncytial virus pneumonia (2 arms), sponsored by Jiangsu Provincial Hospital of Traditional Chinese Medicine. Primary endpoints: Temperature, Cough and 4 more. Planned start May 2022; status: not yet recruiting.
02
Drugs
Lianhua Qingwen
03
Conditions
respiratory syncytial virus pneumonia
Beyond the preview
Go deeper on ChiCTR2200057146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200057146.